Willow Biosciences Enters Multi Year CBG Supply Deal
Willow Biosciences (TSX: WLLW) this morning announced its first multi-year supply agreement. The company is set to provide Cellular Goods
Read more
Willow Biosciences
Willow Biosciences Completes Study On Use Of CBG On Skin
Willow Biosciences (TSX: WLLW) appears to be backing up its proprietary IP with clinical trials. The company this morning announced
Read more
Willow Biosciences: First Commercial Fermentation Of CBG Completed – The Daily Dive
Today on the Daily Dive, we sit down with that of Trevor Peters, CEO of Willow Biosciences (TSX: WLLW). Trevor
Read more
Willow Biosciences Commercializes Fermentation Of CBG At Scale
Cannabinoids have officially been produced at commercial scale via fermentation. The landmark announcement was made by Willow Biosciences (TSX: WLLW)
Read more
Willow Biosciences Completes Warrant Acceleration, Boasts $48.4 Million Cash Position
Willow Biosciences (TSX: WLLW) this morning provided an update on its acceleration of outstanding common share purchase warrants. The company
Read more
Corporate Overview: Willow Biosciences Inc.
Willow Biosciences Inc. (TSX: WLLW) is a small-cap biotechnology company that produces high-purity, pharmaceutical-grade, plant-derived compounds that are the building blocks
Read more
Willow Biosciences Closes $28.8 Million Bought Deal Financing
Willow Biosciences (TSX: WLLW) on Friday closed their previously announced bought deal financing. The company raised a total of $28.8
Read more
Willow Biosciences: Jazz Pharma – GW Pharma Merger Has Positive Read-Through For Company
Last week’s announcement that Jazz Pharmaceuticals plc (NASDAQ: JAZZ) has agreed to buy GW Pharmaceuticals (NASDAQ: GWPH) for US$7.2 billion
Read more
Willow Biosciences Increases Bought Deal Financing To $25.0 Million
Late last night, Willow Biosciences (TSX: WLLW) announced the upsizing of its bought deal financing following strong demand. The company
Read more
Willow Biosciences To Raise $20.0 Million In Bought Deal Financing
Willow Biosciences (TSX: WLLW) this evening announced that it will be conducting a bought deal financing. Lead by Eight Capital
Read more